AHRQ September 25, 2024
Coon R, Holden K

Prescription errors have the potential to cause harm to patients. This article examines challenges to safe prescribing by pharmacists through a human factors lens. It highlights...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Safety
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
HHS: Ozempic, Wegovy will be part of Medicare Part D drug price negotiations this year
HHS announces next 15 drugs selected for price negotiations

Share This Article